nootropic agents

Preferred Label : nootropic agents;

MeSH definition : Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. While no potent nootropic drugs have yet been accepted for general use, several are being actively investigated.; Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms.;

MeSH synonym : agents, nootropic; enhancers, cognitive; nootropics; cognitive enhancers; nootropic drugs; drugs, nootropic; Procognitive Agents; Agents, Procognitive; Anti-Dementia Agents; Agents, Anti-Dementia; Anti Dementia Agents; Antidementia Agents; Agents, Antidementia; Nootropic; Nootropic Agent; Agent, Nootropic; Antidementia Agent; Agent, Antidementia; Cognitive Enhancer; Enhancer, Cognitive; Nootropic Drug; Drug, Nootropic; Procognitive Agent; Agent, Procognitive; Anti-Dementia Agent; Agent, Anti-Dementia; Anti Dementia Agent;

MeSH annotation : CNS agents; from Greek nous, mind; GEN or unspecified: prefer specifics;

Wikipedia link : https://en.wikipedia.org/wiki/Nootropic;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D018697;

UMLS CUI

C0242913;

ATC code(s)
- donepezil [ATC Code]
- galantamine [ATC Code]
- tacrine [ATC Code]
ATC code(s)
- acetylcarnitine [ATC Code]
- aniracetam [ATC Code]
- citicoline [ATC Code]
- meclofenoxate [ATC Code]
- other psychostimulants and nootropics [ATC Code]
- oxiracetam [ATC Code]
- piracetam [ATC Code]
- psychostimulants, agents used for adhd and nootropics [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- nootropic [Disease (Nov.)]
Indexing information
- 1-(4-(2,4-difluorophenyl)piperazin-1-yl)-2-((4-fluorobenzyl)oxy)ethanone [MeSH Supplementary Concept]
- 2-(4-(2-(benzyloxy)acetyl)piperazin-1-yl)benzonitrile [MeSH Supplementary Concept]
- 6-chloro-4-ethyl-3,4-dihydro-2H-thieno(2,3-e)-1,2,4-thiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- GSK239512 [MeSH Supplementary Concept]
- N-(1-azabicyclo(2.2.2)oct-3-yl)-6-quinolinecarboxamide [MeSH Supplementary Concept]
- N-hexanoic-Tyr-Ile-(6) aminohexanoic amide [MeSH Supplementary Concept]
- N-p-nitrobenzoylpyrrolidinyl(4,5-dihydro-4,4,5,5-tetramethyl-3-oxido- 1H-imidazol-3-ium-1-oxyl-2-yl) [MeSH Supplementary Concept]
- TAK-085 [MeSH Supplementary Concept]
- bis(9)-normeptazinol [MeSH Supplementary Concept]
Record concept(s)
- nootropic agents [MeSH concept]
See also inter- (CISMeF)
- Medicinal product acting as antidementia agent (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 8-sulfocholecystokinin octapeptide [MeSH Supplementary Concept]
- ACTH (4-10) [MeSH Supplementary Concept]
- ACTH (4-7), Pro-Gly-Pro- [MeSH Supplementary Concept]
- BI 425809 [MeSH Supplementary Concept]
- Donepezil [MeSH Descriptor]
- Levetiracetam [MeSH Descriptor]
- SA 4503 [MeSH Supplementary Concept]
- TA 0910 [MeSH Supplementary Concept]
- acetylcarnitine [MeSH Descriptor]
- adafenoxate [MeSH Supplementary Concept]
- aniracetam [MeSH Supplementary Concept]
- cerebrolysin [MeSH Supplementary Concept]
- choline [MeSH Descriptor]
- cytidine diphosphate choline [MeSH Descriptor]
- ergoloid mesylates [MeSH Descriptor]
- etimizol [MeSH Descriptor]
- galantamine [MeSH Descriptor]
- meclofenoxate [MeSH Descriptor]
- nefiracetam [MeSH Supplementary Concept]
- nicergoline [MeSH Descriptor]
- nicotinoyl-GABA [MeSH Supplementary Concept]
- oxiracetam [MeSH Supplementary Concept]
- pantogab [MeSH Supplementary Concept]
- piracetam [MeSH Descriptor]
- tacrine [MeSH Descriptor]
- tilavonemab [MeSH Supplementary Concept]
- vinpocetine [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Antidementia agent (substance) [Inactive SNOMED CT concept]
- Medicinal product acting as antidementia agent (product) [SNOMED CT concept]
- nootropic [Disease (Nov.)]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients